UNSPSC 51333602: Setoperone

This classification denotes an anxiolytic with the molecular formula C21H24FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BQ67CS3Q3E, chemically known as 6-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2,3-dihydro-7-methyl-5h-thiazolo(3,2-a)pyrimidin-5-one but generally known as setoperone, which bears US NIH Compound Identifier 68604. European Medicines Agency schedules Setoperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10504MIG.

UNSPSC 51333602 Setoperone is a Commodity code that appears misaligned with recent state and local procurement activity. The code's nominal scope does not match the pharmaceuticals, naloxone, drug deactivation systems, and generic multi-source medications actually being solicited by state and local buyers under this classification.

The most recent opportunities tagged to this code show no genuine setoperone procurement. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to support community health initiatives; the Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released an RFP in January 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota and Oregon. Buyers include county health departments, state HHS agencies, and multi-state cooperative purchasing alliances. Recent activity spans Florida, Texas, and Minnesota. This code shows little relevant recent activity aligned with its nominal scope; the opportunities present suggest a taxonomy mismatch rather than active setoperone procurement at the state and local level.